Insider Stock Trading History of Perseus Acquisition/recapitalization Management, L.l.c.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Perseus Acquisition/recapitalization Management, L.l.c. since year 2005. The trader's CIK number is 1488120. At the time of this reporting, Perseus Acquisition/recapitalization Management, L.l.c. is the Director of Cardiac Science Corp . (stock ticker symbol CSCX). See this page for all insider trading activities at Cardiac Science Corp .


Stock purchases, sales, and option exercises reported by insider Perseus Acquisition/recapitalization Management, L.l.c. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2010-04-13 CSCX Cardiac Science Corp Sale 15,000 1.80 27,060
2010-04-14 CSCX Cardiac Science Corp Sale 17,500 1.85 32,322
2010-04-15 CSCX Cardiac Science Corp Sale 80,200 1.94 155,347
2010-04-08 CSCX Cardiac Science Corp Sale 12,300 1.82 22,398
2010-04-09 CSCX Cardiac Science Corp Sale 4,500 1.83 8,226
2010-04-12 CSCX Cardiac Science Corp Sale 14,400 1.83 26,380
2010-04-05 CSCX Cardiac Science Corp Sale 15,200 1.85 28,074
2010-04-06 CSCX Cardiac Science Corp Sale 8,000 1.85 14,816
2010-04-07 CSCX Cardiac Science Corp Sale 16,200 1.85 29,953
2010-04-01 CSCX Cardiac Science Corp Sale 6,800 1.86 12,668
2010-03-30 CSCX Cardiac Science Corp Sale 14,000 1.88 26,376
2010-03-31 CSCX Cardiac Science Corp Sale 16,900 1.89 31,957
2010-03-25 CSCX Cardiac Science Corp Sale 50,000 1.85 92,400
2010-03-26 CSCX Cardiac Science Corp Sale 25,200 1.87 47,149
2010-03-29 CSCX Cardiac Science Corp Sale 10,600 1.88 19,981

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Perseus Acquisition/recapitalization Management, L.l.c. (Director of Cardiac Science Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.